GSE200538 butyrolactone Hep-G2 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE200538_butyrolactone_Hep-G2_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE200538_butyrolactone_Hep-G2_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE200538_butyrolactone_Hep-G2_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE200538_butyrolactone_Hep-G2_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

polycystin 1, transient receptor potential channel interacting pseudogene 1

Gene

long intergenic non-protein coding RNA 2693

Gene

small nucleolar RNA host gene 33

Gene

HHIP antisense RNA 1

Gene

long intergenic non-protein coding RNA 261

Gene

long intergenic non-protein coding RNA 3033

Gene

MIRLET7I host gene

Gene

PCDHB1 antisense RNA 1

Gene

ZNF516 antisense RNA 1

Gene

MIR4453 host gene

  • Gene

    polycystin 1, transient receptor potential channel interacting pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    small nucleolar RNA host gene 33


  • Gene

    HHIP antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 261


  • Gene

    long intergenic non-protein coding RNA 3033



  • Gene

    PCDHB1 antisense RNA 1


  • Gene

    ZNF516 antisense RNA 1


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.